ESR1 and breast carcinoma: A study of the related enzyme, A3B, in breast cancer found that deaminase activity at estrogen receptor (ER) binding sites resulted in DNA breaks that, upon repair, remodeled chromatin locally to promote ER-dependent gene expression (93).